کد مقاله کد نشریه سال انتشار مقاله انگلیسی نسخه تمام متن
5632424 1406536 2016 7 صفحه PDF دانلود رایگان
عنوان انگلیسی مقاله ISI
Histological effects of givinostat in boys with Duchenne muscular dystrophy
ترجمه فارسی عنوان
اثرات هیستولوژیک گیینوواستات در پسران با دیستروفی عضلانی دوشن
موضوعات مرتبط
علوم زیستی و بیوفناوری علم عصب شناسی علوم اعصاب تکاملی
چکیده انگلیسی


- HDAC hyperactivity is part of DMD pathogenesis. Givinostat is an HDAC inhibitor.
- Givinostat increased muscle and decreased fibrosis and fat replacement in DMD boys.
- Givinostat was tolerated with platelet count reductions being the dose limiting AE.
- Givinostat counteracts the pathogenic events downstream of DMD genetic defect.

Duchenne Muscular Dystrophy (DMD) is caused by mutations in the dystrophin gene leading to dystrophin deficiency, muscle fiber degeneration and progressive fibrotic replacement of muscles. Givinostat, a histone deacetylase (HDAC) inhibitor, significantly reduced fibrosis and promoted compensatory muscle regeneration in mdx mice. This study was conducted to evaluate whether the beneficial histological effects of Givinostat could be extended to DMD boys. Twenty ambulant DMD boys aged 7 to <11 years on stable corticosteroid treatment were enrolled in the study and treated for ≥12 months with Givinostat. A muscle biopsy was collected at the beginning and at the end of treatment to evaluate the amount of muscle and fibrotic tissue. Histological effects were the primary objectives of the study. Treatment with Givinostat significantly increased the fraction of muscle tissue in the biopsies and reduced the amount of fibrotic tissue. It also substantially reduced tissue necrosis and fatty replacement. Overall the drug was safe and tolerated. Improvement in functional tests was not observed in this study, but the sample size of the study was not sufficient to draw definitive conclusions. This study showed that treatment with Givinostat for more than 1 year significantly counteracted histological disease progression in ambulant DMD boys aged 7 to 10 years.

ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Neuromuscular Disorders - Volume 26, Issue 10, October 2016, Pages 643-649
نویسندگان
, , , , , , , , , , , , , , ,